|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.37 USD | +3.72% |
|
+0.64% | -30.36% |
| 10/07 | Pfizer Poised for Mixed Second Quarter, RBC Says | MT |
| 09/07 | Bernstein Adjusts Price Target on NIKE to $72 From $80 | MT |
| Fiscal Period: May | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 4.45TCr | 4.67TCr | 5.12TCr | 5.14TCr | 4.63TCr | |||||
Total Revenues | 4.45TCr | 4.67TCr | 5.12TCr | 5.14TCr | 4.63TCr | |||||
Cost of Goods Sold, Total | 2.45TCr | 2.52TCr | 2.89TCr | 2.84TCr | 2.65TCr | |||||
Gross Profit | 2TCr | 2.15TCr | 2.23TCr | 2.3TCr | 1.98TCr | |||||
Selling General & Admin Expenses, Total | 1.28TCr | 1.48TCr | 1.64TCr | 1.62TCr | 1.61TCr | |||||
Other Operating Expenses, Total | 1.28TCr | 1.48TCr | 1.64TCr | 1.62TCr | 1.61TCr | |||||
Operating Income | 723.1Cr | 667.5Cr | 591.5Cr | 675.4Cr | 370.2Cr | |||||
Interest Expense, Total | -30Cr | -30Cr | -29Cr | -27Cr | -30Cr | |||||
Interest And Investment Income | 3.4Cr | 9.4Cr | 30Cr | 43Cr | 40Cr | |||||
Net Interest Expenses | -26Cr | -20Cr | 60L | 16Cr | 11Cr | |||||
Currency Exchange Gains (Loss) | -22Cr | 22Cr | - | 23Cr | 15Cr | |||||
Other Non Operating Income (Expenses) | 21Cr | 5.8Cr | 28Cr | -2.7Cr | 2.1Cr | |||||
EBT, Excl. Unusual Items | 695.5Cr | 674.7Cr | 620.1Cr | 711.6Cr | 397.7Cr | |||||
Restructuring Charges | -29Cr | - | - | -44Cr | - | |||||
Other Unusual Items | - | -9.6Cr | - | 2.7Cr | -9.2Cr | |||||
EBT, Incl. Unusual Items | 666.1Cr | 665.1Cr | 620.1Cr | 670Cr | 388.5Cr | |||||
Income Tax Expense | 93Cr | 60Cr | 113.1Cr | 100Cr | 67Cr | |||||
Earnings From Continuing Operations | 572.7Cr | 604.6Cr | 507Cr | 570Cr | 321.9Cr | |||||
Net Income to Company | 572.7Cr | 604.6Cr | 507Cr | 570Cr | 321.9Cr | |||||
Net Income - (IS) | 572.7Cr | 604.6Cr | 507Cr | 570Cr | 321.9Cr | |||||
Net Income to Common Incl Extra Items | 572.7Cr | 604.6Cr | 507Cr | 570Cr | 321.9Cr | |||||
Net Income to Common Excl. Extra Items | 572.7Cr | 604.6Cr | 507Cr | 570Cr | 321.9Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.64 | 3.83 | 3.27 | 3.76 | 2.17 | |||||
Basic EPS - Continuing Operations | 3.64 | 3.83 | 3.27 | 3.76 | 2.17 | |||||
Basic Weighted Average Shares Outstanding | 157.3Cr | 157.88Cr | 155.16Cr | 151.76Cr | 148.49Cr | |||||
Net EPS - Diluted | 3.56 | 3.75 | 3.23 | 3.73 | 2.16 | |||||
Diluted EPS - Continuing Operations | 3.56 | 3.75 | 3.23 | 3.73 | 2.16 | |||||
Diluted Weighted Average Shares Outstanding | 160.94Cr | 161.08Cr | 156.98Cr | 152.97Cr | 148.76Cr | |||||
Normalized Basic EPS | 2.76 | 2.67 | 2.5 | 2.93 | 1.67 | |||||
Normalized Diluted EPS | 2.7 | 2.62 | 2.47 | 2.91 | 1.67 | |||||
Dividend Per Share | 1.07 | 1.19 | 1.32 | 1.45 | 1.57 | |||||
Payout Ratio | 28.6 | 30.38 | 39.68 | 38.05 | 71.45 | |||||
American Depositary Receipts Ratio (ADR) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |||||
Supplemental Items | ||||||||||
EBITDA | 802.8Cr | 751.5Cr | 677.4Cr | 759.8Cr | 447.7Cr | |||||
EBITA | 728.4Cr | 679.8Cr | 607.1Cr | 680.2Cr | 370.2Cr | |||||
EBIT | 723.1Cr | 667.5Cr | 591.5Cr | 675.4Cr | 370.2Cr | |||||
EBITDAR | 896.4Cr | 847.4Cr | 776.2Cr | 864.9Cr | 557.2Cr | |||||
Effective Tax Rate - (Ratio) | 14.02 | 9.1 | 18.24 | 14.93 | 17.14 | |||||
Current Domestic Taxes | 46Cr | 33Cr | 61Cr | 98Cr | 48Cr | |||||
Current Foreign Taxes | 86Cr | 93Cr | 63Cr | 51Cr | 48Cr | |||||
Total Current Taxes | 131.9Cr | 125.5Cr | 124.8Cr | 149.7Cr | 95Cr | |||||
Deferred Domestic Taxes | -40Cr | -54Cr | -19Cr | -48Cr | -15Cr | |||||
Deferred Foreign Taxes | 2Cr | -11Cr | 7Cr | -1.4Cr | -14Cr | |||||
Total Deferred Taxes | -38Cr | -65Cr | -12Cr | -50Cr | -29Cr | |||||
Normalized Net Income | 434.69Cr | 421.69Cr | 387.56Cr | 444.75Cr | 248.56Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | 311.4Cr | 385Cr | 406Cr | - | - | |||||
Selling and Marketing Expenses | 311.4Cr | 385Cr | 406Cr | 428.5Cr | 468.9Cr | |||||
Net Rental Expense, Total | 94Cr | 96Cr | 99Cr | 105.1Cr | 109.5Cr | |||||
Imputed Operating Lease Interest Expense | 17Cr | 18Cr | 19Cr | 19Cr | 23Cr | |||||
Imputed Operating Lease Depreciation | 76Cr | 78Cr | 80Cr | 86Cr | 87Cr | |||||
Stock-Based Comp., COGS (Total) | - | - | - | 80L | - | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | - | - | 4.3Cr | - | |||||
Stock-Based Comp., Other (Total) | 61Cr | 64Cr | 76Cr | 75Cr | 71Cr | |||||
Total Stock-Based Compensation | 61Cr | 64Cr | 76Cr | 80Cr | 71Cr |
- Stock Market
- Stocks
- NKE Stock
- Financials Nike, Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















